KR100976005B1 - 만성 류마티스관절염 질환 감수성 유전자, 이의 단백질,이들을 이용한 만성 류마티스관절염의 발증가능성의 판정방법 및 판정 키트, 및 만성 류마티스관절염의 치료 방법및 치료 약제 - Google Patents
만성 류마티스관절염 질환 감수성 유전자, 이의 단백질,이들을 이용한 만성 류마티스관절염의 발증가능성의 판정방법 및 판정 키트, 및 만성 류마티스관절염의 치료 방법및 치료 약제 Download PDFInfo
- Publication number
- KR100976005B1 KR100976005B1 KR1020047010787A KR20047010787A KR100976005B1 KR 100976005 B1 KR100976005 B1 KR 100976005B1 KR 1020047010787 A KR1020047010787 A KR 1020047010787A KR 20047010787 A KR20047010787 A KR 20047010787A KR 100976005 B1 KR100976005 B1 KR 100976005B1
- Authority
- KR
- South Korea
- Prior art keywords
- rheumatoid arthritis
- protein
- onset
- gene
- mutation
- Prior art date
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Rehabilitation Therapy (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
Abstract
Description
평균치(A/B) | 표준편차 (A/B) | |
3 염기 결실형 | 260/43 | 41/7 |
3 염기 삽입형 | 520/87 | 81/14 |
Claims (10)
- 삭제
- 삭제
- 삭제
- 서열번호 1에 나타낸 아미노산 서열을 가지고, 그 서열 중 269번째의 아미노산으로서 글리신 삽입 변이를 가지는 단백질을 암호화하는 유전자의 변이 유무를 생체 밖에서(ex vivo) 검출하는 단계를 포함하는, 만성 류마티스관절염의 발증 또는 이의 발증 가능성을 판정하기 위하여 정보를 제공하는 방법.
- 서열번호 1에 나타낸 아미노산 서열을 가지고, 그 서열 중 269번째의 아미노산으로서 글리신 삽입 변이를 가지는 단백질의 변이 유무를 생체 밖에서(ex vivo) 검출하는 단계를 포함하는, 만성 류마티스관절염의 발증 또는 이의 발증 가능성을 판정하기 위하여 정보를 제공하는 방법.
- 제4항 또는 제5항에 기재된 방법을 이용한, 만성 류마티스관절염의 발증 또는 이의 발증가능성의 판정 키트.
- 만성 류마티스관절염의 발증 또는 이의 발증 가능성을 판정하기 위하여, 서열번호 2에 나타낸 염기 서열 중 805 내지 807번째 염기인 「GGT」의 3 염기를 결실한 염기 서열을 가진 만성 류마티스관절염의 질환 감수성 유전자 유래의 mRNA의 발현량을 측정하는 방법.
- 삭제
- 삭제
- 서열번호 1의 아미노산 서열에서 269번째 아미노산으로서 글리신의 삽입 변이를 갖지 않은 정상형 단백질 또는 당해 정상형 단백질을 암호화하는 DNA, 또는 당해 정상형 단백질이 리간드가 되는 수용체 단백질의 효능제로서의 저분자 화합물을 주성분으로 하는, 서열번호 1의 아미노산 서열을 가지고 그 서열 중 269번째 아미노산으로서 글리신 삽입 변이를 가지는 단백질을 갖는 만성 류마티스관절염의 치료 약제.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2002-00005326 | 2002-01-11 | ||
JP2002005326A JP4242590B2 (ja) | 2002-01-11 | 2002-01-11 | 慢性関節リウマチの疾患感受性遺伝子、及びその利用 |
PCT/JP2003/000089 WO2003060126A1 (fr) | 2002-01-11 | 2003-01-08 | Gene sensible a la polyarthrite rhumatoide, sa proteine, procede et kit permettant d'evaluer l'apparition de la maladie a travers ce gene, ainsi que procede et medicaments pour le traitement de ladite maladie |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040077715A KR20040077715A (ko) | 2004-09-06 |
KR100976005B1 true KR100976005B1 (ko) | 2010-08-17 |
Family
ID=19191091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020047010787A KR100976005B1 (ko) | 2002-01-11 | 2003-01-08 | 만성 류마티스관절염 질환 감수성 유전자, 이의 단백질,이들을 이용한 만성 류마티스관절염의 발증가능성의 판정방법 및 판정 키트, 및 만성 류마티스관절염의 치료 방법및 치료 약제 |
Country Status (11)
Country | Link |
---|---|
US (1) | US7615341B2 (ko) |
EP (1) | EP1471143B1 (ko) |
JP (1) | JP4242590B2 (ko) |
KR (1) | KR100976005B1 (ko) |
AT (1) | ATE387460T1 (ko) |
CA (1) | CA2473218C (ko) |
DE (1) | DE60319342T2 (ko) |
DK (1) | DK1471143T3 (ko) |
ES (1) | ES2301778T3 (ko) |
PT (1) | PT1471143E (ko) |
WO (1) | WO2003060126A1 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4657757B2 (ja) * | 2005-02-23 | 2011-03-23 | 株式会社膠原病研究所 | 肺高血圧症発症関連遺伝子を用いた肺高血圧症の診断および治療 |
JP2006325528A (ja) * | 2005-05-27 | 2006-12-07 | Institute For Rheumatic Diseases Co Ltd | 糖尿病性網膜症の診断および予防 |
JP4657857B2 (ja) * | 2005-08-25 | 2011-03-23 | 株式会社膠原病研究所 | メタボリックシンドロームの診断および予防 |
JP2009136229A (ja) * | 2007-12-07 | 2009-06-25 | Institute For Rheumatic Diseases Co Ltd | 自己免疫疾患モデル細胞又は自己免疫疾患モデル動物の作製方法、並びに自己免疫疾患の診断方法 |
US11434522B1 (en) * | 2015-06-24 | 2022-09-06 | Oxford BioDynamics PLC | Detection of chromosome interactions |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000064946A2 (en) * | 1999-04-28 | 2000-11-02 | Board Of Regents, The University Of Texas System | Compositions and methods for cancer treatment by selectively inhibiting vegf |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5585464A (en) | 1993-02-19 | 1996-12-17 | Theratech, Inc. | Recombinant antigen for diagnosing rheumatoid arthritis |
US5814464A (en) | 1994-10-07 | 1998-09-29 | Regeneron Pharma | Nucleic acids encoding TIE-2 ligand-2 |
ATE273384T1 (de) * | 1995-04-06 | 2004-08-15 | Regeneron Pharma | Tie-2 liganden, herstellungsverfahren und verwendung |
WO1998051791A1 (fr) | 1997-05-15 | 1998-11-19 | Shunichi Shiozawa | Gene responsable de l'arthrite rhumatoide, methode pour diagnostiquer l'arthrite rhumatoide et procede permettant de determiner des facteurs responsables de l'arthrite rhumatoide |
JP2002520297A (ja) * | 1998-07-13 | 2002-07-09 | ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システム | アミノリン脂質に結合する治療結合体を用いる癌処置方法 |
WO2000011164A1 (en) * | 1998-08-20 | 2000-03-02 | Incyte Pharmaceuticals, Inc. | Human angiopoietin-3 |
WO2000056888A1 (fr) * | 1999-03-20 | 2000-09-28 | Shunichi Shiozawa | Gene de la polyarthrite rhumatoide et procede permettant de diagnostiquer la polyarthrite rhumatoide |
DE10100586C1 (de) | 2001-01-09 | 2002-04-11 | Ribopharma Ag | Verfahren zur Hemmung der Expression eines Ziegens |
JP3596433B2 (ja) * | 2000-06-29 | 2004-12-02 | 株式会社デンソー | 車載用電子制御装置 |
AU1092602A (en) | 2000-10-24 | 2002-05-06 | New Ind Res Organization | Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detectingthem and therapeutic method and remedies for rheumatoid arthritis |
-
2002
- 2002-01-11 JP JP2002005326A patent/JP4242590B2/ja not_active Expired - Fee Related
-
2003
- 2003-01-08 KR KR1020047010787A patent/KR100976005B1/ko active IP Right Grant
- 2003-01-08 CA CA2473218A patent/CA2473218C/en not_active Expired - Lifetime
- 2003-01-08 DK DK03700501T patent/DK1471143T3/da active
- 2003-01-08 PT PT03700501T patent/PT1471143E/pt unknown
- 2003-01-08 DE DE60319342T patent/DE60319342T2/de not_active Expired - Lifetime
- 2003-01-08 ES ES03700501T patent/ES2301778T3/es not_active Expired - Lifetime
- 2003-01-08 WO PCT/JP2003/000089 patent/WO2003060126A1/ja active IP Right Grant
- 2003-01-08 EP EP03700501A patent/EP1471143B1/en not_active Expired - Lifetime
- 2003-01-08 AT AT03700501T patent/ATE387460T1/de active
- 2003-01-08 US US10/501,259 patent/US7615341B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000064946A2 (en) * | 1999-04-28 | 2000-11-02 | Board Of Regents, The University Of Texas System | Compositions and methods for cancer treatment by selectively inhibiting vegf |
Also Published As
Publication number | Publication date |
---|---|
AU2003201847A1 (en) | 2003-07-30 |
WO2003060126A1 (fr) | 2003-07-24 |
ATE387460T1 (de) | 2008-03-15 |
EP1471143B1 (en) | 2008-02-27 |
PT1471143E (pt) | 2008-05-20 |
US7615341B2 (en) | 2009-11-10 |
JP2003204790A (ja) | 2003-07-22 |
JP4242590B2 (ja) | 2009-03-25 |
EP1471143A4 (en) | 2005-09-14 |
US20050176004A1 (en) | 2005-08-11 |
CA2473218A1 (en) | 2003-07-24 |
CA2473218C (en) | 2011-07-19 |
DE60319342T2 (de) | 2009-03-19 |
DE60319342D1 (de) | 2008-04-10 |
DK1471143T3 (da) | 2008-06-16 |
ES2301778T3 (es) | 2008-07-01 |
EP1471143A1 (en) | 2004-10-27 |
KR20040077715A (ko) | 2004-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5879884A (en) | Diagnosis of depression by linkage of a polymorphic marker to a segment of chromosome 19P13 bordered by D19S247 and D19S394 | |
JP2007185199A (ja) | 特発性全身てんかんについてのローカス、当該ローカスのミューテーション、及びてんかんの評価、診断、予後、または治療のための当該ローカスの使用方法 | |
KR20110057188A (ko) | 바이오마커 프로파일 측정 시스템 및 방법 | |
CN101103124A (zh) | 用于检测原发性动脉高压风险的方法和试剂盒 | |
JP2009520460A (ja) | 心筋梗塞に関連する遺伝的多型、その検出方法および使用 | |
WO2019005847A1 (en) | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF FIBROTIC PULMONARY DISEASE | |
KR20060061350A (ko) | 골다공증 진단 및 치료 | |
KR100976005B1 (ko) | 만성 류마티스관절염 질환 감수성 유전자, 이의 단백질,이들을 이용한 만성 류마티스관절염의 발증가능성의 판정방법 및 판정 키트, 및 만성 류마티스관절염의 치료 방법및 치료 약제 | |
JP2002527079A (ja) | 心臓血管ステータスを評価するための遺伝子及びその使用のための組成物 | |
US6544742B1 (en) | Detection of genes regulated by EGF in breast cancer | |
US6562574B2 (en) | Association of protein kinase C zeta polymorphisms with diabetes | |
US20050130151A1 (en) | Method and identification of downstream mrna ligands to fmrp and their role in fragile x syndrome and associated disorders | |
WO2021050608A1 (en) | Novel genetic markers for postural orthostatic tachycardia syndrome (pots) and methods of use thereof for diagnosis and treatment of the same | |
EP1627077B1 (en) | Susceptibility gene for alzheimer's disease | |
CA2547033A1 (en) | Ntrk1 genetic markers associated with progression of alzheimer's disease | |
EP2501825B1 (en) | Methods for diagnosing skin diseases | |
KR100890448B1 (ko) | 만성관절류머티즘에 관여하는 게놈dna, 그 진단방법,그 발증가능성의 판정방법, 및 이들의 검출용 진단키트 | |
US20040018497A1 (en) | Human obesity LIPIN3 polynucleotide and polypeptide sequences and methods of use thereof | |
WO2008026233A2 (en) | Single nucleotide polymorphisms on the irak-m gene, related methods, uses and kit for the diagnosis of allergic asthma. | |
WO2001073116A2 (en) | Method for determining osteoporosis susceptibility and/or low bone density and reagents therefor | |
WO2001082776A2 (en) | Methods and compositions for the diagnosis of schizophrenia | |
JP2006516196A (ja) | ハプロタイプ関連に基づく、骨粗鬆症または骨粗鬆症に対する罹患性の診断方法 | |
JP2005224188A (ja) | 骨代謝異常疾患に関連した転写因子に制御される遺伝子の選抜法とその利用 | |
JP2007503806A (ja) | ヒト肥満感受性遺伝子およびその使用 | |
JP2004524846A (ja) | 化学化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130719 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140721 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150716 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160721 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170720 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180719 Year of fee payment: 9 |